Interferon-inducible factor 16 is a novel modulator of glucocorticoid action

FASEB Journal

Volumn 24, Issue 6, 2010, Pages 1700-1713

  Berry, A ^a,b   Matthews, L ^b   Jangani, M ^a   Plumb, J ^c   Farrow, S ^d   Buchan, N ^d   Wilson, P A ^d   Singh, D ^c   Ray, D W ^b,e   Donn, R P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

IFI16; Inflammation; Nuclear receptor; Steroid sensitivity

Indexed keywords

AMYLOID BETA PRECURSOR PROTEIN BINDING FAMILY B,MEMBER 1; AMYLOID BETA PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON INDUCIBLE PROTEIN 16; PROTEIN NEURAL CELL EXPRESSED DEVELOPMENTALLY DOWNREGULATED 9; RGS PROTEIN; RGS14; SIALYLTRANSFERASE; SIALYLTRANSFERASE 4B; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LYMPH FOLLICLE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; TRANSACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOCORTICOIDS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LUNG NEOPLASMS; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION;

EID: 77953513701     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-139998     Document Type: Article

References (51)

1. Kino, T., and Chrousos, G. P. (2001) Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J. Endocrinol. 169, 437-445
2. Franchimont, D., Louis, E., Dupont, P., Vrindts-Gevaert, Y., Dewe, W., Chrousos, G., Geenen, V., and Belaiche, J. (1999) Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures. Dig. Dis. Sci. 44, 1208-1215
3. Van Rossum, E. F., and Lamberts, S. W. (2004) Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog. Horm. Res. 59, 333-357
4. Szatmary, Z., Garabedian, M. J., and Vilcek, J. (2004) Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J. Biol. Chem. 279, 43708-43715
5. Waters, C. E., Stevens, A., White, A., and Ray, D. W. (2004) Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line. J. Endocrinol. 183, 375-383
6. Adcock, I. M., and Ito, K. (2005) Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc. Am. Thorac. Soc. 2, 313-319
7. Donn, R., Berry, A., Stevens, A., Farrow, S., Betts, J., Stevens, R., Clayton, C., Wang, J., Warnock, L., Worthington, J., Scott, L., Graham, S., and Ray, D. (2007) Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J. 21, 402-414
8. Huizenga, N. A., Koper, J. W., de Lange, P., Pols, H. A., Stolk, R. P., Grobbee, D. E., de Jong, F. H., and Lamberts, S. W. (1998) Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J. Clin. Endocrinol. Metab. 83, 47-54
9. Chriguer, R. S., Elias, L. L., da Silva, I. M., Jr., Vieira, J. G., Moreira, A. C., and de Castro, M. (2005) Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies. J. Clin. Endocrinol. Metab. 90, 5978-5984
10. Stevens, A., Ray, D. W., Zeggini, E., John, S., Richards, H. L., Griffiths, C. E., and Donn, R. (2004) Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J. Clin. Endocrinol. Metab. 89, 892-897
11. Van Rossum, E. F., Voorhoeve, P. G., te Velde, S. J., Koper, J. W., Delemarre-van de Waal HA, Kemper, H. C., and Lamberts, S. W. (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89, 4004-4009
12. Mayburd, A. L., Martlinez, A., Sackett, D., Liu, H., Shih, J., Tauler, J., Avis, I., and Mulshine, J. L. (2006) Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin. Cancer Res. 12, 1820-1827
13. Stevens, A., Garside, H., Berry, A., Waters, C., White, A., and Ray, D. (2003) Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Mol. Endocrinol. 17, 845-859
14. Cerami, E. G., Bader, G. D., Gross, B. E., and Sander, C. (2006) cPath: open source software for collecting, storing, and querying biological pathways. BMC Bioinformatics 7, 497
15. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504
16. Kudrin, A., Scott, M., Martin, S., Chung, C. W., Donn, R., McMaster, A., Ellison, S., Ray, D., Ray, K., and Binks, M. (2006) Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J. Biol. Chem. 281, 29641-29651
17. Gugliesi, F., Mondini, M., Ravera, R., Robotti, A., de Andrea, M., Gribaudo, G., Gariglio, M., and Landolfo, S. (2005) Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells. J. Leukoc. Biol. 77, 820-829
18. Alimirah, F., Chen, J., Xin, H., and Choubey, D. (2006) Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein. FEBS Lett. 580, 1659-1664
19. Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., III, Loyd, J. E., Nichols, W. C., and Trembath, R. C. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat. Genet. 26, 81-84
20. Kimple, R. J., Kimple, M. E., Betts, L., Sondek, J., and Siderovski, D. P. (2002) Structural determinants for GoLoco-induced inhibition of nucleotide release by Gα subunits. Nature 416, 878-881
21. Sierra, D. A., Gilbert, D. J., Householder, D., Grishin, N. V., Yu, K., Ukidwe, P., Barker, S. A., He, W., Wensel, T. G., Otero, G., Brown, G., Copeland, N. G., Jenkins, N. A., and Wilkie, T. M. (2002) Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 79, 177-185
22. Law, S. F., Estojak, J., Wang, B., Mysliwiec, T., Kruh, G., and Golemis, E. A. (1996) Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 3327-3337 (Pubitemid 26199852)
23. HEF1, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J. Biol. Chem. 272, 4230-4236
24. Bao, J., Cao, C., Zhang, X., Jiang, F., Nicosia, S. V., and Bai, W. (2007) Suppression of β-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol. Cell. Biol. 27, 1321-1333
25. Lee, E. J., Chun, J., Hyun, S., Ahn, H. R., Jeong, J. M., Hong, S. K., Hong, J. T., Chang, I. K., Jeon, H. Y., Han, Y. S., Auh, C. K., Park, J. I., and Kang, S. S. (2008) Regulation Fe65 localization to the nucleus by SGK1 phosphorylation of its Ser566 residue. BMB Rep. 41, 41-47
26. Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., and Jansen, M. (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab. 88, 277-284
27. Fan, B. J., Wang, D. Y., Tham, C. C., Lam, D. S., and Pang, C. P. (2008) Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone. Invest. Ophthalmol. Vis. Sci. 49, 1886-1897
28. Slatore, C. G., Bryson, C. L., and Au, D. H. (2009) The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am. J. Med. 122, 472-478
29. Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., and Pare, P. D. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653
30. Van der Strate, B. W., Postma, D. S., Brandsma, C. A., Melgert, B. N., Luinge, M. A., Geerlings, M., Hylkema, M. N., van den Berg, A., Timens, W., Kerstjens, H. A. (2006) Cigarette smoke-induced emphysema: a role for the B cell? Am. J. Respir. Crit. Care Med. 173, 751-758
31. Yasukawa, Z., Sato, C., and Kitajima, K. (2005) Inflammation-dependent changes in α2,3-, α2,6-, and α2,8-sialic acid glycotopes on serum glycoproteins in mice. Glycobiology 15, 827-837
32. Szapary, D., Huang, Y., and Simons, S. S., Jr. (1999) Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol. Endocrinol. 13, 2108-2121 (Pubitemid 30637270)
33. Almlof, T., Wright, A. P., and Gustafsson, J. A. (1995) Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J. Biol. Chem. 270, 17535-17540
34. Ismaili, N., and Garabedian, M. J. (2004) Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 1024, 86-101
35. Ismaili, N., Blind, R., and Garabedian, M. J. (2005) Stabilization of the unliganded glucocorticoid receptor by TSG101. J. Biol. Chem. 280, 11120-11126
36. Alimirah, F., Chen, J., Davis, F. J., and Choubey, D. (2007) IFI16 in human prostate cancer. Mol. Cancer Res. 5, 251-259
37. Trapani, J. A., Dawson, M., Apostolidis, V. A., and Browne, K. A. (1994) Genomic organization of IFI16, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: correlation of predicted protein domains with exon organization. Immunogenetics 40, 415-424 (Pubitemid 24330198)
38. Johnstone, R. W., and Trapani, J. A. (1999) Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol. Cell. Biol. 19, 5833-5838
39. Adcock, I. M., and Caramori, G. (2001) Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 79, 376-384
40. Reichardt, H. M., Tuckermann, J. P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., and Schutz, G. (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168-7173
41. Johnstone, R. W., Kershaw, M. H., and Trapani, J. A. (1998) Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing. Biochemistry 37, 11924-11931
42. Kimkong, I., Avihingsanon, Y., and Hirankarn, N. (2009) Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR. Lupus 18, 1066-1072
43. Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., Lambert, M. H., Moore, J. T., Pearce, K. H., and Xu, H. E. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110, 93-105
44. Doucas, V., Shi, Y., Miyamoto, S., West, A., Verma, I., Evans, R. M. (2000) Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U. S. A. 97, 11893-11898
45. Rangarajan, P. N., Umesono, K., and Evans, R. M. (1992) Modulation of glucocorticoid receptor function by protein kinase A. Mol. Endocrinol. 6, 1451-1457
46. Gariglio, M., Azzimonti, B., Pagano, M., Palestro, G., de, A. M., Valente, G., Voglino, G., Navino, L., Landolfo, S. (2002) Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J. Interferon Cytokine Res. 22, 815-821
47. Adcock, I. M., Gilbey, T., Gelder, C. M., Chung, K. F., and Barnes, P. J. (1996) Glucocorticoid receptor localization in normal and asthmatic lung. Am. J. Respir. Crit. Care Med. 154, 771-782 (Pubitemid 26327304)
48. Fiorentino, L., Stehlik, C., Oliveira, V., Ariza, M. E., Godzik, A., and Reed, J. C. (2002) A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-α and interleukin-1β. J. Biol. Chem. 277, 35333-35340
49. Min, W., Ghosh, S., and Lengyel, P. (1996) The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-κB, c-Fos, and c-Jun activities. Mol. Cell. Biol. 16, 359-368 (Pubitemid 126506982)
50. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797-807
51. Ma, X. Y., Wang, H., Ding, B., Zhong, H., Ghosh, S., Lengyel, P. (2003) The interferon-inducible p202a protein modulates NF-κB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J. Biol. Chem. 278, 23008-23019